SHUAA Capital invests in Swiss pharma supply chain disruptor SkyCell

Its managed funds have invested in the recently concluded CHF32mln (USD34.8mln) Series C funding round by SkyCell


United Arab Emirates : SHUAA Capital psc (DFM: SHUAA), the leading asset management and investment banking platform in the region, has announced that its managed funds have invested in the recently concluded CHF 32 million (USD 34.8 million) Series C funding round by SkyCell, the Swiss pharma-tech supply chain company which manufactures smart containers enabling the safe, secure and sustainable transportation of pharmaceutical products.

This investment is part of SkyCell's latest funding round, which was completed in order to support SkyCell’s continued growth and build a strong partner network including in the Middle East.

Commenting on this new investment, Ajit Joshi, MD, Head of Public & Private Markets at SHUAA Capital,said: “SkyCell is an exciting disruptor in the pharmaceutical supply chain, bringing together the latest in software, hardware and big data in order to transform this specialised logistics space. Given its pioneering approach and the significant potential for value creation, it represents a great fit for SHUAA’s stringent investment criteria and we are pleased to be supporting SkyCell’s continued growth.”

Richard Ettl, co-founder and CEO of SkyCell, said: “At SkyCell, we continue to work on expanding our business network through diversification of funding sources. This investment will contribute to raising the efficiency of our services and targeting new markets in the region and in SHUAA, we have found an investor aligned with our vision and ambitions. Therefore, we are delighted to have partnered with SHUAA in this fundraising round and look forward to a productive relationship going forward.”

Founded in Switzerland in 2012, SkyCell designs and manufactures smart containers that allow pharmaceutical companies to predict, reduce, and control the risks associated with transporting temperature-sensitive drugs. Powered by a growing pool of nearly one billion data points on factors including carriers, handlers, airports, outside temperatures, locations, and transit times, SkyCell’s combination of hardware and software innovation delivers an independently-audited market-leading failure rate of less than 0.1 per cent - versus an accepted industry standard between 4 and 12 per cent - while reducing CO2 emissions by almost half.


Press Contacts
SHUAA Capital psc
Hani El Abid
Head of Marketing and Communications
Tel: +971 4 3199 723
Dhanya Issac
Associate Director
Tel: +971 4 450 7600

About SHUAA Capital psc

SHUAA Capital psc (DFM: SHUAA) is a leading asset management and investment banking platform, with c. USD 14 billion in assets under management. SHUAA Capital psc is recognized for its strong track record and pioneering approach to investing through a differentiated, innovative and global product offering focused on public and private markets, debt and real estate.

The asset management segment, one of the region’s largest, manages real estate funds and projects, investment portfolios and funds in the regional equities, fixed income and credit markets; it also provides investment solutions to clients, with a focus on alternative investment strategies. The investment banking segment provides corporate finance advisory, transaction services, private placement, public offerings of equity and debt securities, while also creating market liquidity on OTC fixed income products. The firm is regulated as a financial investment company by the Securities and Commodities Authority.

To learn more about SHUAA Capital, please visit:

About SkyCell

SkyCell is a purpose-led technology company transforming the pharmaceutical supply chain through a combination of proprietary software, hardware, and big data. It is the leading manufacturer of temperature-controlled door-to-door container solutions that allow pharma companies to optimize their supply chain by reducing, and even predicting, the risks associated with delivering sensitive drugs by air. Its SaaS solution, SkyCell SECURE, enables pharma companies to have real-time, end-to-end oversight of every shipment around the world, and its automated approval capability reduces quality approval time from an average of 14 days to just hours, getting life-changing drugs to consumers faster.

Designed with sustainability as a core principle, SkyCell’s technologies protect healthcare systems by reducing in-transit failure rate to a market-leading low of less than 0.1% temperature excursions and reduce the CO2 impact of each shipment by almost half the average rate. SkyCell is operationally climate-neutral today and has committed to the goal of end-to-end climate neutrality by 2040. SkyCell’s sustainability targets are science led and aligned to both the Paris Agreement and UN sustainable development goals.

Founded in Switzerland in 2012 with a vision to have zero loss in the pharma supply chain, the company has been validated by the majority of the top 20 pharma companies. SkyCell is a leading player in the world in temperature-controlled air freight solutions, in a market currently worth USD 2.8 billion per annum and growing at a rate of 15 to 20%. 

Cautionary Statement Regarding Forward-Looking Information:

This document contains forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Forward-looking statements can be identified by words such as: "anticipate," "aspire," "intend," "plan," "goal," "objective," "seek," "believe," "project," "estimate," "expect," "forecast," "strategy," "target," "trend," "future," "likely," "may," "should," "will" and similar references to future periods.

Examples of forward-looking statements include, among others, statements we make regarding:

  • Expected operating results, such as revenue growth and earnings.
  • Anticipated levels of expenditures and uses of capital
  • Current or future volatility in the capital and credit markets and future market conditions.

Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: Our ability to maintain adequate revenue levels and cost control; economic and financial conditions in the global markets and regional markets in which we operate, including volatility in interest rates, commodity and equity prices and the value of assets; the implementation of our strategic initiatives, including our ability to effectively manage the redeployment of our balance sheet and the expansion of our strategic businesses; the reliability of our risk management policies, procedures and methods; continued volatility in the capital or credit markets; geopolitical events; developments and changes in laws and regulations, including increased regulation of the financial services industry through legislative action and revised rules and standards applied by our regulators.

Any forward-looking statement made by us in this document and presentation is based only on information currently available to us and speaks only as of the date on which it is made. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions contained in this document. We undertake no obligation to publicly update any forward-looking statement whether as a result of new information, future developments or otherwise.

Please remember that past performance may not be indicative of future results.

Send us your press releases to

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases